FTC sues important pharmacy reward supervisors over insulin rates The agency introduced motion against Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the record cost of lifestyle-preserving insulin prescription drugs. Earlier this summer months, the firm held prolonged negotiations with Steward around tips https://buschpeachcalories86160.suomiblog.com/everything-about-healthcare-news-46314589